Health-Industry PAC Money: $6,000, Then $85,250, Then $193,000. What Changed Was His Committee Seat. Who Gave, What They Hold From the Government, and What He Did With the Seat.

Campaign Finance / Health Care Source: Press releases, Office of Rep. Langworthy ('Congressman Langworthy Named to House Energy and Commerce Committee'; 'Congressman Langworthy Introduces CHECK Act') DOCUMENTED PATTERN

Original source → · Archived copy →

Why this matters

On December 13, 2024, Rep. Langworthy announced his appointment to the House Energy and Commerce Committee, calling its “broad jurisdiction over energy, healthcare, telecommunications, and more” an “unparalleled opportunity to influence the issues that impact families across the Southern Tier and Western New York.” He took a seat on its Health Subcommittee, which writes Medicaid law and much of federal drug and device policy. He also sits on the Oversight Committee, whose written jurisdiction includes federal procurement.

A reader asked this site a plain question: how many of his donors do business with the federal government? This entry answers it for the health sector first, because that is where his donor list changed most after the appointment, and because the companies involved are paid by the same programs his subcommittee writes.

The statements

Source: Press release, December 13, 2024.

“With the committee’s broad jurisdiction over energy, healthcare, telecommunications, and more, we have an unparalleled opportunity to influence the issues that impact families across the Southern Tier and Western New York.”

Source: Press release, June 3, 2026, introducing the CHECK Act.

“The CHECK Act shines a light on the hidden costs and middlemen driving up healthcare expenses, gives patients clear and understandable information about their services, and helps protect families from surprise charges.”

Neither statement is false. The first is the frame for what follows: the seat changed who funds him. The second is the standard he set for others, transparency about who is paid and by whom, and it is the standard this entry applies to his own filings.

Part 1: What changed after the appointment

Health-industry political action committees are identified here by one rule applied to all three cycles: the PAC’s name or its sponsoring organization, as recorded in the FEC’s committee master file, is a pharmaceutical, device, diagnostic, insurance, provider, pharmacy or health trade group. Veterinary, auto-care and energy PACs that match on a word are excluded. Receipts are to his campaign committee and, from 2023, his leadership PAC, Circle the Wagons; memo entries are excluded.

CycleAll PAC receiptsHealth-industry PACsShareHis committees
2021-22$203,224$6,000 (3 contributions)3.0%Candidate; seated January 2023 on Agriculture, Oversight, Rules
2023-24$895,436$85,250 (55)9.5%Agriculture, Oversight, Rules
2025-26 (through September 30)$1,276,689$193,000 (63)15.1%Energy and Commerce (Health, Energy, Environment), Oversight, Rules

By type of donor:

Type2021-222023-242025-26
Pharmaceutical, device and diagnostic companies$0$5,500$62,000
Insurers and federal health-program contractors$1,000$25,250$44,000
Provider, pharmacy and trade associations$5,000$54,500$87,000

Twelve corporate health PACs that had never given to him gave in the 2026 cycle: Amgen ($10,500), Pfizer ($5,000), Biogen, DaVita and Laboratory Corporation of America ($3,500 each), AstraZeneca, Edwards Lifesciences and Eli Lilly ($3,000 each), Alnylam, BioMarin and Bristol-Myers Squibb ($2,500 each) and Genentech ($2,000). Each of them gives to members of the Health Subcommittee in both parties as a matter of course.

In plain language: his total PAC money grew by about 43 percent from the last cycle to this one. His health-industry PAC money grew by about 126 percent. Drug and device company money went from $5,500 to $62,000. The change tracks the seat, not the election calendar.

Part 2: The Medicaid plans that cover his district

Medicaid managed care in New York is run by private plans under state contract. The state Department of Health publishes enrollment by county and plan every month. For September 2026, in the eight counties that make up or overlap NY-23, mainstream Medicaid managed care enrollment was 259,558 people. (Erie County is counted whole; only part of it is in the district.)

PlanParent companyEnrollees, eight countiesParent’s PAC to him, 2023-242025-26
Fidelis CareCentene Corporation123,120$1,000$1,000
Independent Health AssociationIndependent Health (Buffalo nonprofit)60,653$0$0
Highmark Western and Northeastern New YorkHighmark Inc.33,926$2,250$3,000
Molina Healthcare of New YorkMolina Healthcare26,428$0$2,000
UnitedHealthcareUnitedHealth Group9,622$10,000$6,000
Excellus Health PlanExcellus (Rochester nonprofit)5,809$0$0

Plans owned by companies whose PACs gave to him cover 193,096 of the 259,558 enrollees, 74 percent. Outside Erie County, where Independent Health and Excellus do not operate, every one of the 87,512 mainstream Medicaid managed care enrollees in Allegany, Cattaraugus, Chautauqua, Chemung, Schuyler, Steuben and Tioga counties is in a plan whose parent company’s PAC has given to him. Fidelis Care alone covers 68,579 of them. Fidelis identifies itself on its own website as a trademark of Centene Corporation.

The sums are small: $12,000 from the four parent companies this cycle, $13,250 last cycle. The relationship is not. These are the companies paid by the state, with federal matching funds, to run the program his subcommittee rewrote in 2025.

In plain language: when he voted for the Medicaid provisions of H.R. 1, the companies that would administer the result in his district were already his donors. Their interest and his vote did not point the same way, which the fair-reading section below takes up.

Part 3: What his health donors hold from the federal government

USAspending.gov records federal contract obligations by recipient. The figures below sum fiscal 2023 through fiscal 2026 (October 2022 through September 2026) for each company’s recipient family, reviewed by hand to drop unrelated companies that share a name. Medicaid managed care payments are state contracts and do not appear here; the table is federal awards only.

Donor PAC’s sponsorFederal contract obligations, FY2023-2026Principal federal businessPAC to him, 2025-26
UnitedHealth Group (Optum Public Sector Solutions)$81.3 billionTRICARE regional contract, VA community care$6,000
McKesson$44.9 billionPharmaceutical distribution to VA and federal programs$2,000
Centene (Health Net Federal Services)$8.6 billionTRICARE regional contract$1,000
Maximus$6.0 billionMedicare and Marketplace call centers, eligibility services$1,000
Pfizer$1.8 billionVaccines and drugs$5,000
GuideWell (Novitas Solutions, First Coast Service Options)$1.2 billionMedicare Administrative Contractor, claims processing$1,000
Elevance Health (Wellpoint Federal Solutions)$1.0 billionFederal health program administration$10,000
DaVita$965 millionDialysis, principally VA$3,500
Abbott Laboratories$793 millionDiagnostics and devices$1,000
Amgen$560 millionDrugs$10,500
Roche (Roche Diagnostics, Genentech)$635 millionDiagnostics and drugs$3,000
Laboratory Corporation of America$455 millionLaboratory services$3,500
Merck$197 millionVaccines and drugs$1,000
Edwards Lifesciences$108 millionHeart valves and devices$3,000
US Renal Care$96 millionDialysis$2,000

Several of his health donors do not appear in federal award data at all because their government business is state Medicaid contracting: MVP Health Care ($7,000 this cycle, $4,000 last), Molina, Highmark’s health plans, and the Blue Cross Blue Shield Association ($5,500).

In plain language: a dozen of his health-industry donors are among the federal government’s largest health contractors. The two biggest, UnitedHealth’s Optum and Centene’s Health Net, hold the military health system’s regional contracts. Two others, GuideWell and Maximus, are paid to run Medicare’s claims and call centers.

Part 4: What he has done with the two seats

The Oversight Committee’s jurisdiction over contracts

House Rule X, clause 1(n)(6), gives the Committee on Oversight and Government Reform jurisdiction over the “overall economy, efficiency, and management of government operations and activities, including Federal procurement.” Clause 4(c)(2) adds that the committee “may at any time conduct investigations of any matter without regard to” the clauses giving another committee jurisdiction. It is the one House committee that can examine any federal contract.

He has sat on that committee since January 2023. The Clerk’s member data lists him on the full committee only, with no subcommittee assignment. An earlier entry found him absent for 69 of the committee’s 145 recorded votes.

The committee did use that jurisdiction on health contractors while he was a member. Between 2023 and 2024 it held three hearings on pharmacy benefit managers and on July 23, 2024 published a report naming CVS Caremark, Express Scripts and OptumRx, the last of which is a UnitedHealth subsidiary. The report and the chairman’s release are retained.

His record on the one issue the committee pursued

On pharmacy benefit managers his votes are consistent and run against one of his largest health donors:

DateMeasureHis voteResult
December 11, 2023H.R. 5378, Lower Costs, More Transparency Act, with PBM provisionsYeaPassed 320 to 71
December 20, 2024H.R. 10545, American Relief Act, the funding bill from which PBM reform had been droppedYeaPassed 366 to 34
February 3, 2026H.R. 7148, Consolidated Appropriations Act, 2026, which enacted Medicare Part D delinking for PBMsYeaPassed 217 to 214
June 3, 2026Introduced the CHECK Act, requiring PBM and third-party administrator disclosureSponsorReferred

After the December 2024 vote he wrote that he “remain[ed] committed to … pursuing much-needed reforms to hold Pharmacy Benefit Managers accountable.” The February 2026 law delivered part of that. The Energy and Commerce chairman’s release on the signing is retained.

His record where the donors’ interests and his votes diverge

  • Medicaid. He voted Yea on H.R. 1 on May 22, 2025 (Roll Call 145) and July 3, 2025 (Roll Call 190). The law’s Medicaid provisions reduce enrollment, which reduces the per-member payments the plans in Part 2 receive. The committee-record entry and the rural impact summary document the district effect.
  • Nursing homes. The same law blocked the federal nursing-home staffing rule until 2034. Two entries document $55,000 from one nursing-home operator and $150,800 from six Kentucky nursing-home companies through a joint fundraising committee.
  • Oncology. One entry documents $55,137 from a Long Island cancer network’s doctors and PACs, the last check 15 days before he introduced a biosimilars bill whose economics favor practices like theirs. This cycle the same network’s employees gave $11,291 and two oncology PACs gave $20,000.

What he has said

In 149 press releases from his office between April 2025 and September 2026, retained for an earlier entry, pharmacy benefit managers appear in three. Medicare Advantage, UnitedHealth, Elevance, Centene, Fidelis, Maximus and dialysis appear in none. On October 20, 2026 he posted that, “as a member of the Energy and Commerce Committee,” he was “committed to rooting out waste, fraud, and abuse” in Medicaid.

The fair reading, at full strength

  • This is how the Health Subcommittee is funded, for everyone on it. Pharmaceutical, device and insurer PACs give to nearly every member of the subcommittee in both parties. A member who joins it and does not see this money would be the exception. The growth documented in Part 1 is what the seat does, not something he did.
  • The amounts are modest. $193,000 is 15 percent of his PAC money and about 8 percent of everything he raised this cycle. The four companies that run his district’s Medicaid plans gave $12,000 between them.
  • His Medicaid vote cut against the plans’ revenue. Managed care companies are paid per enrollee. A law that reduces enrollment reduces their income. Whatever the merits of H.R. 1, it was not a vote for these donors’ interest.
  • His PBM votes cut against UnitedHealth. OptumRx is one of the three PBMs the Oversight report named. He voted for PBM reform three times and introduced a disclosure bill. UnitedHealth’s PAC gave to him before and after.
  • Everything here is lawful and disclosed. The contributions are in his FEC reports. The contracts are in USAspending. The enrollment figures are the state’s. No donor gave more than the legal limit and no filing shows a contribution tied to any act.
  • A member cannot investigate everything. The Oversight Committee’s agenda is set by its chairman. A rank-and-file member without a subcommittee seat has limited means to open a contractor inquiry on his own.

What the record supports is narrower than a charge and still worth knowing: the seat he described as an “unparalleled opportunity to influence” health policy was followed, within one cycle, by a health-industry donor base he did not have before, and that donor base includes the companies paid to run Medicaid in every one of his counties and several of the largest health contractors in the federal government.

Claims and findings

ItemFinding
Health-industry PAC money by cycle$6,000 (3.0%), $85,250 (9.5%), $193,000 (15.1%) of PAC receipts. DOCUMENTED.
Drug and device company PACs$0, $5,500, $62,000; twelve first-time corporate donors in 2025-26. DOCUMENTED.
Medicaid plans in his districtPlans owned by his PAC donors cover 74 percent of mainstream Medicaid managed care enrollees in the eight counties and 100 percent outside Erie County. DOCUMENTED.
Federal contractors among his health donorsAt least fifteen hold federal contracts, led by UnitedHealth ($81.3 billion), McKesson ($44.9 billion), Centene ($8.6 billion) and Maximus ($6.0 billion), FY2023-2026. DOCUMENTED.
Oversight jurisdictionExplicit over federal procurement under Rule X; he has no subcommittee seat and missed 69 of 145 recorded votes. DOCUMENTED.
Any contribution tied to any voteNOT CLAIMED.

Overall: DOCUMENTED PATTERN.

What is still unaddressed

ItemStatus
The same analysis for his non-health donors (defense, energy, telecommunications)Pilot run; 128 corporate PAC sponsors, 65 matched to federal contract recipients by name, not yet reviewed by hand. A separate entry if pursued.
Post-general FEC reportsDue December 3, 2026; the 2025-26 figures above run through September 30.
Individual donors’ employers680 itemized contributions this cycle; health-sector employers account for about $66,000, most of it already documented in the oncology entry. Not matched to contracts, since an employee’s gift says nothing about the employer.
Whether he signed the annual House letters supporting Medicare Advantage payment ratesNot checked.
Oversight Committee health-contractor work in the 119th CongressThe committee’s 2025-26 Medicaid letters, retained for an earlier entry, concern state eligibility practices, not contractors. No contractor inquiry located.

Questions this raises

  1. What accounts for the change? Twelve drug and device PACs gave to him for the first time within eighteen months of his appointment. Did his office solicit them, and does he see the seat as the reason?
  2. Has he used the Oversight seat on any health contractor? The committee’s jurisdiction over procurement is explicit. Has he asked for or joined any inquiry into a Medicare, Medicaid or TRICARE contractor, including the ones on his donor list?
  3. Does the CHECK Act’s disclosure standard apply to him? The bill would require PBMs and administrators to disclose “detailed claims, reimbursement, pricing, fee, rebate, and payment information.” Would he publish, in his own announcements, the health-industry contributions his committees receive while health bills are pending?
  4. What did the Medicaid plans tell him before the H.R. 1 votes? Fidelis, Highmark, Molina and UnitedHealthcare administer the program for every enrollee outside Erie County. Did they contact his office about the enrollment provisions, and what did he tell them?

Sources

Note: This entry documents publicly available campaign finance, procurement and enrollment records. It makes no claim that any contribution influenced any vote or that any donor received anything in return. The sector classification rule and every excluded name collision are in the retained README so the count can be reproduced or disputed.

Last updated: November 5, 2026